OncoSec Announces 1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
| ONCSDelisted Stock | USD 0.06 0 3.63% |
Slightly above 61% of OncoSec Medical's investor base is looking to short. The analysis of current outlook of investing in OncoSec Medical suggests that many traders are alarmed regarding OncoSec Medical's prospects. OncoSec Medical's investing sentiment can be driven by a variety of factors including economic data, OncoSec Medical's earnings reports, geopolitical events, and overall market trends.
OncoSec |
OncoSec Medical Incorporated , a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patients immune system to target cancer cells and eradicate disease, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 1,408,384 shares of its common stock , at a purchase price of 0.945 per share or common stock equivalent
Read at finance.yahoo.com
 |
OncoSec Medical Fundamental Analysis
We analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
OncoSec Medical is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
OncoSec Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OncoSec Medical stock to make a market-neutral strategy. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics with similar companies.
Peers
OncoSec Medical Related Equities
| ZVSA | ZyVersa Therapeutics | 13.76 | ||||
| VRAX | Virax Biolabs | 9.95 | ||||
| IMMX | Immix Biopharma | 6.82 | ||||
| QNRX | Quoin Pharmaceuticals | 4.48 | ||||
| PHIO | Phio Pharmaceuticals | 3.68 | ||||
| DRMA | Dermata Therapeutics | 2.88 | ||||
| PALI | Palisade Bio | 2.15 | ||||
| BDRX | Biodexa Pharmaceticals | 0.99 | ||||
| REVB | Revelation Biosciences | 1.52 | ||||
| UNCY | Unicycive Therapeutics | 2.47 | ||||
| ALLR | Allarity Therapeutics | 4.50 | ||||
| ATNF | 180 Life | 5.49 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |